Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Growth 2025-2031

The global Pharmaceutical Excipients for Oral Solid Dosage Forms market size is predicted to grow from US$ 25630 million in 2025 to US$ 35150 million in 2031; it is expected to grow at a CAGR of 5.4% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Pharmaceutical excipients for oral solid preparations refer to substances other than active ingredients added to pharmaceutical preparations. They are used to improve the physical and chemical properties of preparations, enhance drug stability, promote or control drug release, improve the feasibility of the production process, and optimize the patient's medication experience. These excipients include fillers, binders, disintegrants, lubricants, glidants, coating materials, sweeteners, flavoring agents, and colorants, etc. They are widely used in the manufacturing process of various oral solid preparations such as tablets, capsules, and granules to ensure the effectiveness, safety, and patient compliance of drugs.

United States market for Pharmaceutical Excipients for Oral Solid Dosage Forms is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Pharmaceutical Excipients for Oral Solid Dosage Forms is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Pharmaceutical Excipients for Oral Solid Dosage Forms is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Pharmaceutical Excipients for Oral Solid Dosage Forms players cover Dow, JRS Pharma, BASF, Lubrizol, Ashland, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Forecast” looks at past sales and reviews total world Pharmaceutical Excipients for Oral Solid Dosage Forms sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Excipients for Oral Solid Dosage Forms sales for 2025 through 2031. With Pharmaceutical Excipients for Oral Solid Dosage Forms sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Excipients for Oral Solid Dosage Forms industry.

This Insight Report provides a comprehensive analysis of the global Pharmaceutical Excipients for Oral Solid Dosage Forms landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Excipients for Oral Solid Dosage Forms portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Excipients for Oral Solid Dosage Forms market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Excipients for Oral Solid Dosage Forms and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Excipients for Oral Solid Dosage Forms.

This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Excipients for Oral Solid Dosage Forms market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Fillers
Binders
Disintegrants
Lubricants
Coating Materials
Other

Segmentation by Application:
Tablets
Capsules
Granules and Powders

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Dow
JRS Pharma
BASF
Lubrizol
Ashland
Croda International
Roquette
Shin-Etsu
Evonik
Associated British Foods
Südzucker AG
Mitsubishi
Hunan Er-Kang Pharmaceutical Co., Ltd.
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.
Tianjin Chasesun Pharmaceutical Co., Ltd.
Xiwang Group
Sunrise Manufacture Group Co., Ltd.
Nanjing Well Pharmaceutical Group Co.,Ltd.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pharmaceutical Excipients for Oral Solid Dosage Forms market?

What factors are driving Pharmaceutical Excipients for Oral Solid Dosage Forms market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pharmaceutical Excipients for Oral Solid Dosage Forms market opportunities vary by end market size?

How does Pharmaceutical Excipients for Oral Solid Dosage Forms break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver. Show more